600062.SS
China Resources Double-Crane Pharmaceutical Co.,Ltd.
ShanghaiCNYEQUITY
Healthcare
DELAYED
Last price
15.67
▼ 0.54 (3.33%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
16.11
Prev close
16.21
Day high
16.11
Day low
15.57
Volume
12.59M
Market cap
$16.27B
P/E (TTM)
9.98
52W range
15.29 – 20.35
Day trading desk
Gap from prior close
-0.62%
Prior close 16.21
VWAP
15.69
-0.16% from price
Relative volume
1.31×
Normal
Session range
3.47%
15.57 – 16.11
Position in range
19%
Near session low
ATR (14D)
0.37
2.37% of price
Prior day high
16.29
PDH
Prior day low
15.98
PDL
Bid / ask spread
—
Quote not published
Session volume
11.83M
Avg 9.04M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.06%
-0.7%
1M
-8.42%
-12.1%
3M
-6.78%
-9.9%
6M
-16.20%
-27.3%
YTD
-14.32%
-26.6%
1Y
-22.27%
-42.3%
3Y
-10.15%
-84.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 600062.SS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
642.32M
Total on file
Fundamentals
Market cap$16.27B
Enterprise value$15.69B
Revenue (TTM)$10.73B
Gross profit$6.13B
EBITDA$2.41B
Net income$1.63B
EPS (TTM)$1.57
Free cash flow$129.00M
Total cash$3.07B
Total debt$1.69B
Book value / share$11.26
Shares outstanding1.04B
Float400.09M
Short % of float—
Dividend yield3.06%
Beta (5Y)-0.07
Valuation & profitability ratios
Trailing P/E9.98
Forward P/E8.42
PEG ratio—
Price / sales—
Price / book1.39
EV / revenue1.46
EV / EBITDA6.51
Gross margin57.18%
Operating margin19.88%
Profit margin15.15%
Return on equity13.49%
Return on assets5.85%
Debt / equity12.99
Current ratio2.67
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $11.00B | $11.21B | $11.31B | $9.63B | -1.9% |
| Operating revenue | $11.00B | $11.21B | $11.31B | $9.63B | -1.9% |
| Cost of revenue | $4.62B | $4.79B | $4.87B | $4.29B | -3.6% |
| Gross profit | $6.38B | $6.42B | $6.44B | $5.34B | -0.6% |
| Research & development | $531.60M | $555.19M | $627.85M | $482.48M | -4.2% |
| Selling, general & admin | $2.30B | $2.48B | $2.05B | $2.30B | -7.2% |
| Total operating expense | $4.59B | $4.73B | $4.64B | $4.00B | -3.0% |
| Operating income | $1.79B | $1.69B | $1.80B | $1.33B | +6.1% |
| Net interest income | -$8.09M | $26.65M | $37.52M | $76.62M | -130.4% |
| Pre-tax income | $1.91B | $1.87B | $1.94B | $1.43B | +2.4% |
| Tax provision | $227.52M | $215.94M | $272.71M | $201.27M | +5.4% |
| Net income | $1.65B | $1.63B | $1.67B | $1.18B | +1.2% |
| Net income to common | $1.65B | $1.63B | $1.67B | $1.18B | +1.2% |
| Basic EPS | 1.59 | 1.58 | 1.63 | 1.14 | +0.7% |
| Diluted EPS | 1.59 | 1.58 | 1.63 | 1.14 | +0.6% |
| EBIT | $1.94B | $1.88B | $1.95B | $1.45B | +3.3% |
| EBITDA | $2.73B | $2.64B | $2.64B | $2.01B | +3.6% |
| Basic shares | 1.03B | 1.03B | 1.02B | 1.04B | +0.5% |
| Diluted shares | 1.03B | 1.03B | 1.02B | 1.04B | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.91B | $2.85B | $3.46B | $2.63B | -32.8% |
| Cash & short-term investments | $2.42B | $2.85B | $3.46B | $2.83B | -15.3% |
| Accounts receivable | $2.03B | $1.76B | $1.73B | $1.34B | +15.2% |
| Inventory | $1.58B | $1.59B | $1.69B | $1.90B | -1.0% |
| Total current assets | $7.11B | $7.48B | $9.38B | $7.64B | -4.9% |
| Property, plant & equipment | $4.45B | $4.24B | $4.05B | $3.57B | +4.9% |
| Goodwill & intangibles | $3.62B | $3.35B | $3.47B | $3.35B | +8.0% |
| Total assets | $17.01B | $16.69B | $18.20B | $15.17B | +1.9% |
| Total current liabilities | $3.02B | $4.00B | $4.78B | $3.08B | -24.5% |
| Current debt | $105.55M | $63.55M | $29.97M | $4.95M | +66.1% |
| Long-term debt | $1.04B | $1.09B | — | $200.00M | -4.9% |
| Total debt | $1.19B | $1.21B | $291.22M | $264.99M | -1.1% |
| Total liabilities | $4.51B | $5.57B | $5.30B | $3.84B | -19.1% |
| Retained earnings | $10.36B | $9.24B | $10.12B | $8.93B | +12.1% |
| Shareholder equity | $11.63B | $10.41B | $12.21B | $10.56B | +11.8% |
| Working capital | $4.09B | $3.47B | $4.60B | $4.56B | +17.6% |
| Net tangible assets | $8.01B | $7.06B | $8.75B | $7.20B | +13.6% |
| Shares issued | 1.04B | 1.04B | 1.04B | 1.04B | -0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.68B | $1.65B | $1.66B | $1.23B | +2.0% |
| Depreciation & amortisation | $788.40M | $755.54M | $690.35M | $561.85M | +4.3% |
| Change in working capital | -$931.42M | -$471.11M | -$447.74M | -$374.86M | -97.7% |
| Operating cash flow | $1.49B | $1.83B | $1.86B | $1.42B | -18.4% |
| Capital expenditure | -$619.63M | -$637.50M | -$614.31M | -$526.60M | +2.8% |
| Investing cash flow | -$1.05B | $982.46M | -$783.37M | $592.28M | -206.5% |
| Dividends paid | -$716.05M | -$1.48B | -$305.89M | -$801.76M | +51.6% |
| Financing cash flow | -$1.37B | -$3.18B | -$489.85M | -$1.29B | +56.9% |
| Free cash flow | $869.88M | $1.19B | $1.24B | $889.57M | -26.8% |
| End cash position | $1.91B | $2.84B | $3.21B | $2.61B | -32.8% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $2.81B | $2.72B | — | $2.66B | $3.08B | $2.66B | +3.3% |
| Operating revenue | $2.81B | $2.72B | — | $2.66B | $3.08B | $2.66B | +3.3% |
| Cost of revenue | $1.15B | $1.25B | — | $1.09B | $1.22B | $1.24B | -7.9% |
| Gross profit | $1.66B | $1.47B | — | $1.57B | $1.86B | $1.42B | +12.7% |
| Research & development | $111.42M | $160.41M | — | $117.08M | $116.37M | $82.50M | -30.5% |
| Selling, general & admin | $962.02M | -$665.68M | $1.84B | $41.26M | $1.09B | — | +244.5% |
| Total operating expense | $1.07B | $1.22B | — | $1.02B | $1.22B | $1.18B | -12.3% |
| Operating income | $583.26M | $245.30M | — | $545.22M | $644.13M | $240.48M | +137.8% |
| Net interest income | -$12.70M | -$4.48M | — | -$3.20M | $1.30M | $1.42M | -183.3% |
| Pre-tax income | $601.00M | $289.89M | — | $566.30M | $656.20M | $249.33M | +107.3% |
| Tax provision | $99.63M | -$5.12M | — | $76.55M | $133.48M | $10.36M | +2,047.0% |
| Net income | $484.87M | $297.41M | — | $468.82M | $506.67M | $230.65M | +63.0% |
| Net income to common | $484.87M | $297.41M | — | $468.82M | $506.67M | $230.65M | +63.0% |
| Basic EPS | 0.47 | — | — | — | 0.49 | — | — |
| Diluted EPS | 0.47 | — | — | — | 0.49 | — | — |
| EBIT | $608.56M | $298.81M | — | $574.61M | $664.81M | $255.02M | +103.7% |
| EBITDA | $608.56M | $298.81M | — | $574.61M | $664.81M | $255.02M | +103.7% |
| Basic shares | 1.03B | — | — | — | 1.03B | — | — |
| Diluted shares | 1.04B | — | — | — | 1.03B | — | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.57B | $1.91B | $2.02B | $3.12B | $2.85B | +34.3% |
| Cash & short-term investments | $3.07B | $2.42B | $2.53B | $3.12B | $2.85B | +27.1% |
| Accounts receivable | $2.42B | $2.03B | $2.34B | $2.40B | $1.76B | +18.8% |
| Inventory | $1.50B | $1.58B | $1.62B | $1.50B | $1.59B | -5.2% |
| Total current assets | $8.05B | $7.11B | $7.57B | $8.15B | $7.48B | +13.3% |
| Property, plant & equipment | $4.55B | $4.45B | $4.22B | $4.23B | $4.24B | +2.4% |
| Goodwill & intangibles | $3.59B | $3.62B | $3.23B | $3.25B | $3.35B | -0.8% |
| Total assets | $18.01B | $17.01B | $16.74B | $17.29B | $16.69B | +5.9% |
| Total current liabilities | $3.01B | $3.02B | $3.40B | $4.09B | $4.00B | -0.4% |
| Current debt | $100.00M | $105.55M | $15.11M | $60.92M | $63.55M | -5.3% |
| Long-term debt | $1.54B | $1.04B | $1.10B | $1.09B | $1.09B | +48.8% |
| Total debt | $1.69B | $1.19B | $1.17B | $1.20B | $1.21B | +41.3% |
| Total liabilities | $5.00B | $4.51B | $4.96B | $5.65B | $5.57B | +11.0% |
| Retained earnings | $10.85B | $10.36B | $9.84B | $9.75B | $9.24B | +4.7% |
| Shareholder equity | $12.12B | $11.63B | $11.04B | $10.92B | $10.41B | +4.2% |
| Working capital | $5.04B | $4.09B | $4.17B | $4.07B | $3.47B | +23.4% |
| Net tangible assets | $8.53B | $8.01B | $7.81B | $7.67B | $7.06B | +6.4% |
| Shares issued | 1.04B | 1.04B | 1.04B | 1.04B | 1.04B | -0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Capital expenditure | -$108.84M | -$186.54M | -$113.92M | -$126.89M | -$115.59M | +41.7% |
| Investing cash flow | $5.44M | -$530.01M | -$561.36M | -$21.35M | -$113.48M | +101.0% |
| Dividends paid | -$6.66M | -$110.37M | -$206.90M | -$6.90M | -$206.67M | +94.0% |
| Financing cash flow | $486.80M | -$110.03M | -$883.06M | -$25.18M | -$113.74M | +542.4% |
| Free cash flow | $61.77M | $155.79M | $231.17M | $190.19M | $245.87M | -60.4% |
| End cash position | $2.57B | $1.91B | $2.01B | $3.11B | $2.84B | +34.5% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | 1.70 | 2 | $11.59B | +5.4% |
| Next year | 1.81 | 2 | $12.18B | +5.1% |
Analyst targets & ownership
Mean target$25.33
High target$25.65
Low target$25.00
Implied upside61.61%
Analyst count2
ConsensusNONE
Strong buy / Buy0 / 2
Hold0
Sell / Strong sell0 / 0
Held by insiders62.18%
Held by institutions2.88%
Institutions holding108
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
16.14
-2.89% from price
SMA 20
16.26
-3.60% from price
SMA 50
16.55
-5.31% from price
SMA 100
17.13
-8.50% from price
SMA 200
17.88
-12.37% from price
EMA 12
16.11
-2.76% from price
EMA 26
16.32
-4.01% from price
EMA 50
16.57
-5.43% from price
RSI (14)
38.3
Neutral
MACD (12,26,9)
-0.21
Hist -0.04
ATR (14)
0.37
2.37% of price
Realised vol 30D
28.2%
Annualised
Bollinger upper
16.82
20, 2σ
Bollinger lower
15.69
20, 2σ
50 / 200 cross
Death
16.55 vs 17.88
Trend bias
Below 200
-12.37%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.05
Less volatile than market
Correlation to SPY
-0.03
Largely independent
Realised vol 30D
28.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-23.6%
Peak to trough
Max drawdown 5Y
-57.0%
Peak to trough
ATR 14
0.37
2.37% of price
Beta (reported)
-0.07
5Y monthly, from filing
Dividends & splits
Forward rate$0.48 / yr
Forward yield3.06%
5-year avg yield2.42%
Payout ratio30.05%
Ex-dividend dateJul 28, 2026
Next pay date—
Last split1.2:1
Split dateAug 16, 2018
Headlines
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?
Motley Fool · 5m ago
Vistra Is the Quietest Big Winner of the AI Power Boom. Here's Why.
Motley Fool · 6m ago
AstraZeneca Made a $1.5 Billion Lung Cancer Bet, but Can Zegfrovy Strengthen its Oncology Growth?
Insider Monkey · 6m ago
Uber faces fine of nearly $1B over automated driver suspensions
TechCrunch · 15m ago
This Company Has Raised Its Dividend for 72 Straight Years. Almost Nobody Talks About It.
Motley Fool · 17m ago
This Chinese Tech Giant Quietly Cut Its Buyback 80% to Fund AI
24/7 Wall St. · 27m ago
Look Back: Long before Party on the Patio, Mötley Crüe rocked Pocono Downs
The Times-Leader (Wilkes-Barre, Pa.) · 28m ago
Prediction: ExxonMobil Raises Its Dividend More Than Wall Street Expects
Motley Fool · 29m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.